Contributor content
Presentation
The HEP-COVID Trial
Presentation
State of the Art - Optimizing the prevention of venous thromboembolism
Presentation
MARINER.
Presentation
MARINER - Medically Ill Patient Assessment of Rivaroxaban Versus Placebo IN Reducing Post-Discharge Venous Thrombo-Embolism Risk
Presentation


